Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial
Raphael J. Landovitz(APLA Health), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Matthew A. Spinelli(University of California, San Francisco), Adeola Adeyeye(National Institutes of Health), Myron S. Cohen(University of North Carolina at Chapel Hill), Estelle Piwowar‐Manning(Johns Hopkins University), Trần Việt Hà(University of North Carolina at Chapel Hill), Marybeth McCauley(Family Health International 360), James F. Rooney(Gilead Sciences (United States)), Esper G. Kallás(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Craig W. Hendrix(Unknown), Peter L. Anderson(University of Colorado Denver), Sheldon D. Fields(Pennsylvania State University), Omar Sued(Fundación Huésped), Jonathan Lucas(Family Health International 360), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Hyman Scott(UCLA Medical Center), Manya Magnus(Milken Institute), Carlos del Rı́o(Emory University), Philip A. Sullivan(Johns Hopkins University), Susan H. Eshleman(Johns Hopkins University), Ryan Kofron(APLA Health), Mark A. Marzinke(Family Health International 360), Brett Hanscom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Alex R. Rinehart, Richard Berman(The Christie NHS Foundation Trust), Joe Eron(University of North Carolina at Chapel Hill), Jorge Sánchez(Universitat Politècnica de València), Paul A. Richardson(Johns Hopkins University), Meredith E. Clement(Louisiana State University Health Sciences Center New Orleans)
Cited by 70
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k